Latest News and Press Releases

UPPSALA, Sweden, Dec. 19, 2003 (PRIMEZONE) -- With reference to that the American regulatory authority, Food And Drug Administration, FDA, has approved RESTYLANE for sales in USA, Q-Med has now...

UPPSALA, Sweden, Dec. 12, 2003 (PRIMEZONE) -- The FDA (Food and Drug Administration), the American regulatory authority, has approved RESTYLANE for sales in USA. The FDA's approval of RESTYLANE...

UPPSALA, Sweden, Dec. 9, 2003 (PRIMEZONE) -- The German authorities have decided that treatment by injection for urinary incontinence shall be included in the so-called Diagnosis Related Groups...

STOCKHOLM, Sweden, Nov. 21, 2003 (PRIMEZONE) -- The FDA, Food and Drug Administration, the American regulatory authority, convened an advisory panel on Friday with some of the world's leading experts...

UPPSALA, Sweden, Oct. 17, 2003 (PRIMEZONE) -- Q-Med (Other OTC:QMDAF): - Turnover during the first nine months amounted to SEK 427.8 (369.5) million, of which SEK 145.1 (116.1) million was during...

UPPSALA, Sweden, Sept. 17, 2003 (PRIMEZONE) -- Q-Med (Other OTC:QMDAF): The American regulatory authority FDA, Food and Drug Administration, has now confirmed that RESTYLANE is scheduled for an...

UPPSALA, Sweden, Sept. 11, 2003 (PRIMEZONE) -- Q-Med AB has for some time had discussion with the American regulatory authority FDA, Food and Drug Administration, regarding a possible advisory panel...

UPPSALA, Sweden, Sept. 8, 2003 (PRIMEZONE) -- Q-Med in Sweden has been informed by the FDA (Food and Drug Administration), the American regulatory authority, that the company's application to...

UPPSALA, Sweden, July 24, 2003 (PRIMEZONE) -- Q-Med AB: - Sales increased by 12 percent during the first six months. Adjusted for changes in exchange rates, sales increased by 20 percent. -...

UPPSALA, Sweden, May 12, 2003 (PRIMEZONE) -- Q-Med Ab (Publ): -- Pia Rudengren and Asa Roden, new members of the Board -- No dividend for the financial year 2002 -- Nomination committee...